Aquestive Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
125.5M
on 2026-06-30, from 90.5M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
1 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-11 is not read yet.
Cash
8.7 quarters
$98.5M on 2026-06-30 ÷ $11.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-08-14 | Public offering | 21,250,000 | $4.00 | $85.0M | 424B5 ↗ |
Also on file: up to $20.0M term loan agreed 2026-05-13 8-K ↗